Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Metolazone measurement (procedure) |
Component |
True |
Metolazone (substance) |
Inferred relationship |
Some |
1 |
Product containing metolazone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metolazone (substance) |
Inferred relationship |
Some |
1 |
Metolazone adverse reaction |
Causative agent (attribute) |
True |
Metolazone (substance) |
Inferred relationship |
Some |
1 |
Allergy to metolazone (finding) |
Causative agent (attribute) |
False |
Metolazone (substance) |
Inferred relationship |
Some |
|
Metolazone 5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Metolazone (substance) |
Inferred relationship |
Some |
|
Metolazone 2.5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Metolazone (substance) |
Inferred relationship |
Some |
|
Metolazone 10 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Metolazone (substance) |
Inferred relationship |
Some |
|
Product containing precisely metolazone 500 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Metolazone (substance) |
Inferred relationship |
Some |
|
Allergy to metolazone (finding) |
Causative agent (attribute) |
True |
Metolazone (substance) |
Inferred relationship |
Some |
1 |
Administration of prophylactic metolazone (procedure) |
Direct substance |
False |
Metolazone (substance) |
Inferred relationship |
Some |
2 |
Metolazone 5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Metolazone (substance) |
Inferred relationship |
Some |
1 |
Metolazone 5 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Metolazone (substance) |
Inferred relationship |
Some |
1 |
Metolazone 2.5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Metolazone (substance) |
Inferred relationship |
Some |
1 |
Metolazone 2.5 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Metolazone (substance) |
Inferred relationship |
Some |
1 |
Metolazone 10 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Metolazone (substance) |
Inferred relationship |
Some |
1 |
Metolazone 10 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Metolazone (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely metolazone 500 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Metolazone (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely metolazone 500 microgram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Metolazone (substance) |
Inferred relationship |
Some |
1 |
Metolazone 10 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Metolazone (substance) |
Inferred relationship |
Some |
1 |
Metolazone 2.5 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Metolazone (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely metolazone 500 microgram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Metolazone (substance) |
Inferred relationship |
Some |
1 |
Metolazone 5 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Metolazone (substance) |
Inferred relationship |
Some |
1 |
Product containing metolazone in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metolazone (substance) |
Inferred relationship |
Some |
1 |
Product containing only metolazone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metolazone (substance) |
Inferred relationship |
Some |
1 |
Product containing only metolazone in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metolazone (substance) |
Inferred relationship |
Some |
1 |
Administration of prophylactic metolazone (procedure) |
Direct substance |
True |
Metolazone (substance) |
Inferred relationship |
Some |
1 |